These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11641081)

  • 1. [Vaccine coverage survey per cluster sampling after an antimeningococcal mass vaccination campaign at Niamey, Niger in 2000].
    de Chabalier F; Garba A; Chippaux JP
    Sante; 2001; 11(3):173-6. PubMed ID: 11641081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001].
    Renevey F; Demierre G; Chuard C; Regamey C
    Rev Med Suisse Romande; 2001 Aug; 121(8):569-72. PubMed ID: 11565217
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention.
    Grais RF; Ferrari MJ; Dubray C; Bjørnstad ON; Grenfell BT; Djibo A; Fermon F; Guerin PJ
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):867-73. PubMed ID: 16540134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MeNZB vaccine and epidemic control: when do you stop vaccinating?
    Loring BJ; Turner N; Petousis-Harris H
    Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004).
    Dubray C; Gervelmeyer A; Djibo A; Jeanne I; Fermon F; Soulier MH; Grais RF; Guerin PJ
    Vaccine; 2006 May; 24(18):3984-9. PubMed ID: 16540214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quebec's $100-million campaign targets meningococcal disease.
    Pinker S
    CMAJ; 2001 Nov; 165(11):1520. PubMed ID: 11762581
    [No Abstract]   [Full Text] [Related]  

  • 9. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selection of annotated web sites devoted to documentation-health (updated as for July 2001)].
    Mouillet E
    Sante; 2001; 11(3):201-7. PubMed ID: 11641085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Grabowsky M; Nobiya T; Ahun M; Donna R; Lengor M; Zimmerman D; Ladd H; Hoekstra E; Bello A; Baffoe-Wilmot A; Amofah G
    Bull World Health Organ; 2005 Mar; 83(3):195-201. PubMed ID: 15798843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cluster of meningococcal diseases in Allgaeu -- strategies for intervention].
    Hautmann W; Harms I; Vogel U; Zirngibl A; Wildner M
    Gesundheitswesen; 2005 Dec; 67(12):853-7. PubMed ID: 16379047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Invasive meningococcal disease in Opolskie Voivodeship between 2005-2010].
    Posmyk U; Hryniewicz W; Skoczyńska A; Kumala R
    Pol Merkur Lekarski; 2012 May; 32(191):287-92. PubMed ID: 22779333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy.
    Ameratunga S; Macmillan A; Stewart J; Scott D; Mulholland K; Crengle S;
    Vaccine; 2005 Mar; 23(17-18):2231-4. PubMed ID: 15755602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease in Australia: 1997 and beyond.
    Harvey BM
    Commun Dis Intell; 1998 Jul; 22(7):134-5. PubMed ID: 9684531
    [No Abstract]   [Full Text] [Related]  

  • 19. A possible outbreak of Streptococcus pneumoniae invasive infection in children in Ibadan, Nigeria.
    Fashae KF; Ogunsola FT; Salawu OM; Dada AO; Popoola O
    Afr J Med Med Sci; 2002 Jun; 31(2):141-3. PubMed ID: 12518910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Snake bites and antivenom availability in the urban community of Niamey, Niger].
    Chippaux JP; Kambewasso A
    Bull Soc Pathol Exot; 2002 Aug; 95(3):181-3. PubMed ID: 12404866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.